10.1097/jto.0b013e3182937317
Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer: A Randomized Phase 2 PrECOG Study (PrE0501)
- Publication date
- 2013
- Publisher
- Elsevier BV
Abstract
Abstract is not available.